| Literature DB >> 28911647 |
Lin Wang1, Ying Zhao2, Qing Zhou3, Chun-Li Luo1, Ai-Ping Deng3, Zi-Cheng Zhang1, Jiu-Liang Zhang1,4,5.
Abstract
The hepatoprotective activity of anthocyanin-rich purple sweet potato extract (APSPE) was demonstrated. Sixty mice were randomly divided into six groups: control group [without carbon tetrachloride (CCl4) or APSPE]; model group (with CCl4 only); positive control group (50 mg/kg body weight silymarin); low-dose group (100 mg/kg body weight APSPE); medium-dose group (200 mg/kg body weight APSPE); and high-dose group (400 mg/kg body weight APSPE). After 10 days intragastric administration of the respective supplements, the mice in all groups except control were injected intraperitoneally with CCl4 (0.15% in arachis oil, 10 mL/kg body weight, intravenous). Twelve hours after CCl4 injection, the mice were measured in terms of liver index, levels of aspartate aminotransferase and alanine aminotransferase in serum, as well as glutathione, superoxide dismutase, and malondialdehyde in liver homogenate. Additionally, the livers of mice were stained with hematoxylin and eosin and sectioned for observation. Nineteen purple sweet potato anthocyanins were identified from the purple sweet potato cultivar Eshu No. 8 and analyzed by liquid chromatography- electrospray ionization-tandem mass spectrometry. Peonidin 3-coumaryl-p-hydroxybenzoyl sophoroside-5-glucoside was first identified in purple sweet potato. The results showed that anthocyanins in Eshu No. 8 had good hepatoprotective activity.Entities:
Keywords: anthocyanins; characterization; hepatoprotective activity; purple sweet potato (Ipomoea batatas L.)
Mesh:
Substances:
Year: 2016 PMID: 28911647 PMCID: PMC9328810 DOI: 10.1016/j.jfda.2016.10.009
Source DB: PubMed Journal: J Food Drug Anal Impact factor: 6.157
Figure 1High-performance liquid chromatography–diode array detection chromatograms of anthocyanins from purple sweet potato powder (Ipomoea batatas L. cultivar Eshu No. 8) detected at 525 nm.
Identification of anthocyanins from purple sweet potato powder (Ipomoea batatas L. cultivar Eshu No. 8) by high-performance liquid chromatography–electrospray ionization–tandem mass spectrometry.
| Peak | tR (min) | Formula | [M+] (m/z) | Major fragment ion (m/z) | Identification | Quantitation (mg/g) | Reference |
|---|---|---|---|---|---|---|---|
| 1 | 24.6 | C40H45O23 | 893 | 731, 449, 287 | Cyanidin 3-p-hydroxybenzoyl sophoroside-5-glucoside | 0.858 |
|
| 2 | 25.5 | C42H47O24 | 935 | 773, 449, 287 | Cyanidin 3-(6‴-caffeoyl sophoroside)-5-glucoside | 0.339 |
|
| 3 | 28.1 | C41H47O23 | 907 | 745, 463, 301 | Peonidin 3-p-hydroxybenzoyl sophoroside-5-glucoside | 7.10 |
|
| 4 | 28.7 | C43H49O24 | 949 | 787, 463, 301 | Peonidin 3-(6‴-caffeoyl sophoroside)-5-glucoside | 2.29 |
|
| 5 | 29.6 | C43H49O24 | 949 | 787, 449, 287 | Cyanidin 3-feruloyl sophoroside-5-glucoside | 2.04 |
|
| 6 | 32.6 | C44H51O24 | 963 | 801, 463, 301 | Peonidin 3-feruloyl sophoroside-5-glucoside | 7.12 |
|
| 7 | 34.2 | C42H47O24 | 935 | 773, 449 287 | Cyanidin 3-caffeoyl sophoroside-5-glucoside | 13.1 |
|
| 8 | 34.9 | C33H41O21 | 773 | 611, 449, 287 | Cyanidin 3-sophoroside-5-glucoside | 4.44 |
|
| 9 | 35.4 | C51H53O27 | 1097 | 935, 449, 287 | Cyanidin 3-dicaffeoyl sophoroside-5-glucoside | 12.2 |
|
| 10 | 35.7 | C49H51O26 | 1055 | 893, 449, 287 | Cyanidin 3-caffeoyl-p-gydroxybenzoyl sophoroside-5-glucoside | 14.8 |
|
| 11 | 36.4 | C43H49O24 | 949 | 787, 463, 301 | Peonidin-3-caffeoyl sophoroside-5-glucoside | 32.5 |
|
| 12 | 37.4 | C52H55O27 | 1111 | 949, 449 | Cyanidin 3-caffeoyl-feruloyl sophoroside-5-glucoside | 16.2 |
|
| 13 | 38.2 | C52H55O27 | 1111 | 949, 463 | Peonidin 3-dicaffeoyl sophoroside-5-glucoside | 57.9 |
|
| 14 | 38.8 | C50H53O26 | 1069 | 907, 463, 301 | Peonidin 3-caffeoyl-p-hydroxybenzoyl sophoroside-5-glucoside | 75.7 |
|
| 15 | 40.8 | C53H57O27 | 1125 | 963, 463 | Peonidin 3-caffeoyl-feruloyl sophoroside-5-glucoside | 69.2 |
|
| 16 | 41.1 | C52H55O26 | 1095 | 933, 463, 301 | Peonidin 3-caffeoyl-p-coumaryl sophoroside-5-glucoside | 5.59 |
|
| 17 | 42.6 | C51H55O26 | 1083 | 921, 463, 301 | Peonidin 3-feruloyl-p-hydroxybenzoyl sophoroside-5-glucoside | 5.81 |
|
| 18 | 43.4 | C50H53O25 | 1053 | 891, 463, 301 | Peonidin 3-coumaryl-p-hydroxybenzoyl sophoroside-5-glucoside | 1.81 |
|
| 19 | 43.9 | C54H59O27 | 1139 | 977, 463 | Peonidin 3-(6″, 6‴-diferuloyl sophoroside)-5-glucoside | 2.43 |
|
Anthocyanin identified for the first time in purple sweet potato in this paper.
tR = retention time.
Figure 2(A) High-performance liquid chromatography–tandem mass spectrometry; (B) Chemical structures of Peaks 2 and 7.
Figure 3(A) High-performance liquid chromatography–tandem mass spectrometry; (B) Chemical structures of Peaks 4, 5, and 11.
Figure 4(A) High-performance liquid chromatography–tandem mass spectrometry; (B) Chemical structures of Peaks 12 and 13.
Figure 5(A) High-performance liquid chromatography–tandem mass spectrometry; (B) Chemical structures of Peak 18.
Figure 6Effect of the liver index on carbon tetrachloride (CCl4)-induced damage in mice. The liver index on a fresh weight basis was calculated according to the following formula: Liver index (%) = [weight of liver (g)/final body weight (g)] × 100. model group: CCl4 (0.15% in arachis oil, 10 mL/kg body weight, intravenous); silymarin (50 mg/kg body weight) + CCl4 injection; low-dose group: anthocyanin-rich purple sweet potato extract (APSPE; 100 mg/kg body weight) + CCl4 injection; medium-dose group: APSPE (200 mg/kg body weight) + CCl4 injection; high-dose group: APSPE (400 mg/kg body weight) + CCl4 injection.
Effects of anthocyanin-rich purple sweet potato extract (APSPE) administration on the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), in serum in the liver damaged mice induced by carbon tetrachloride (CCl4).
| Group | Treatment | AST (U/L) | ALT (U/L) |
|---|---|---|---|
| I | Control | 28.4 ± 7.93 a | 39.1 ± 3.74 a |
| II | CCl4 (10 mL/kg bw, i.p.) | 107 ± 14.3d | 298 ± 16.9 e |
| III | CCl4 + silymarin (50 mg/kg bw, p.o.) | 79.2 ± 11.9b | 230 ± 14.9 c |
| IV | CCl4 + APSPE (100 mg/kg bw, p.o.) | 91.2 ± 9.07c | 269 ± 16.3d |
| V | CCl4 + APSPE (200 mg/kg bw, p.o.) | 82.2 ± 9.90b | 231 ± 21.5c |
| VI | CCl4 + APSPE (400 mg/kg bw, p.o.) | 71.3 ± 8.55b | 176 ± 9.68b |
Values are expressed as mean ± standard deviation (n = 10).
Different letters indicate significant differences (P < 0.05).
bw = body weight; i.p. = intraperitoneally; p.o. = per os.
Effects of anthocyanin-rich purple sweet potato extract (APSPE) administration on malondialdehyde (MDA) and glutathione (GSH) levels as well as superoxide dismutase (SOD) activities in liver homogenate in the liver damaged mice induced by carbon tetrachloride (CCl4).
| Group | Treatment | MDA (nmol/mg protein) | SOD (U/mg protein) | GSH (nmol/mg protein) |
|---|---|---|---|---|
| I | Control | 4.52 ± 0.38a | 320 ± 6.17 ab | 2.02 ± 0.16 a |
| II | CCl4 (10 mL/kg bw, i.p.) | 7.04 ± 0.66d | 280 ± 4.88c | 1.58 ± 0.12c |
| III | CCl4 + silymarin (50 mg/kg bw, p.o.) | 5.18 ± 0.49b | 319 ± 11.58a | 1.73 ± 0.15ab |
| IV | CCl4 + APSPE (100 mg/kg bw, p.o.) | 5.98 ± 0.47c | 288 ± 8.68c | 1.67 ± 0.11bc |
| V | CCl4 + APSPE (200 mg/kg bw, p.o.) | 5.32 ± 0.37b | 317 ± 9.32a | 1.81 ± 0.15b |
| VI | CCl4 + APSPE (400 mg/kg bw, p.o.) | 5.15 ± 0.48ab | 330 ± 7.53b | 2.06 ± 0.12a |
Values are expressed as mean ± standard deviation (n = 10).
Different letters indicate significant differences (P < 0.05).
bw = body weight; i.p. = intraperitoneally; p.o. = per os.
Figure 7Effect of anthocyanin-rich purple sweet potato extract (APSPE; 100 mg/kg body weight, 200 mg/kg body weight, and 400 mg/kg body weight) and silymarin on liver histopathology of carbon tetrachloride (CCl4)-treated mice. (A) liver section of the normal control group; (B) liver section of the CCl4-injured model group; (C) liver section of the positive control group with silymarin (50 mg/kg body weight) + CCl4 injection; (D) liver section of the low-dose group with APSPE (100 mg/kg body weight) + CCl4 injection; (E) liver section of the medium-dose group with APSPE (200 mg/kg body weight) + CCl4 injection; (F) liver section of the high-dose group with APSPE (400 mg/kg body weight) + CCl4 injection. Magnification 200×. Scale bar: 100 μm.